Literature DB >> 1337845

Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man.

D S Goldstein1, A Breier, O M Wolkowitz, D Pickar, J W Lenders.   

Abstract

Acute cellular glucopenia after 2-deoxy-D-glucose administration profoundly stimulates hypothalamic-pituitary-adrenocortical and adrenomedullary activity. Whether glucopenia stimulates sympathoneural release of noradrenaline is unclear. We studied 20 healthy subjects who received 2-deoxy-D-glucose (50 mg/kg in 100 ml isotonic saline) or isotonic saline (100 ml) i.v. for 30 min on each of 2 test days. Heart rate and blood pressure were measured with antecubital venous blood obtained via an indwelling catheter for assays of plasma catecholamines (noradrenaline; adrenaline; dihydroxyphenylalanine; dihydroxyphenylglycol; and dihydroxyphenylacetic acid), corticotrophin, cortisol, and glucose. 2-deoxy-D-glucose decreased diastolic blood pressure by 20% (from 69 +/- 2 to 55 +/- 2 mmHg) and increased adrenaline levels by 30-fold [21 +/- 6 (SEM) to 634 +/- 73 pg/ml], corticotrophin by sevenfold (5.1 +/- 1.2 to 35.8 +/- 4.9 pg/ml), glucose and cortisol by two-fold (82 +/- 5 to 163 +/- 9 mg/dl and 15 +/- 2 to 31 +/- 2 micrograms/dl), and noradrenaline by about 30% (224 +/- 15 to 295 +/- 24 pg/ml, p < 0.05), whereas plasma dihydroxyphenylglycol levels decreased (765 +/- 56 to 628 +/- 42 pg/ml). Small decreases in dihydroxyphenylalanine and dihydroxyphenylacetic acid levels after 2-deoxy-D-glucose did not differ from those after saline. Responses of adrenaline levels were positively correlated with those of noradrenaline (r = 0.47, p < 0.05) and glucose (r = 0.45, p = 0.06), but not of corticotrophin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337845     DOI: 10.1007/bf01831392

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  34 in total

1.  Effect of chronic active immunization with antiarginine vasopressin on pituitary-adrenal function in sheep.

Authors:  V Guillaume; B Conte-Devolx; E Magnan; F Boudouresque; M Grino; M Cataldi; L Muret; A Priou; J C Figaroli; C Oliver
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

2.  Changes of sympathetic nerve activity induced by 2-deoxy-D-glucose infusion in humans.

Authors:  J Fagius; C Berne
Journal:  Am J Physiol       Date:  1989-06

3.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

4.  Comparison of the effects of 2-deoxyglucose and immobilization on plasma levels of catecholamines and corticosterone in awake rats.

Authors:  C L Sun; N B Thoa; I J Kopin
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

5.  [Adrenaline and noradrenaline concentration in blood of suprarenal and renal vein in man with normal blood pressure and with essential hypertension (author's transl)].

Authors:  G Planz; R Planz; M Persigehl; H D Bundschu; R Heintz
Journal:  Klin Wochenschr       Date:  1978-11-15

6.  Direct evidence that an increase in aortic norepinephrine level in response to insulin-induced hypoglycemia is due to increased adrenal norepinephrine output.

Authors:  N Yamaguchi; R Briand; M Brassard
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

7.  Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia.

Authors:  P M Plotsky; T O Bruhn; W Vale
Journal:  Endocrinology       Date:  1985-07       Impact factor: 4.736

8.  Sympathetic control of hepatic glycogenolysis during glucopenia in man.

Authors:  R G Brodows; R G Campbell
Journal:  Metabolism       Date:  1975-05       Impact factor: 8.694

9.  Effects of 2-deoxy-D-glucose on the cardiac sympathetic nerves and the adrenal medulla in the rat: further evidence for a dissociation of sympathetic nervous system and adrenal medullary responses.

Authors:  E B Rappaport; J B Young; L Landsberg
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

10.  The effect of 2-deoxy-D-glucose and D-glucose on the efferent discharge rate of sympathetic nerves.

Authors:  A Niijima
Journal:  J Physiol       Date:  1975-09       Impact factor: 5.182

View more
  4 in total

Review 1.  Sympathoneural and adrenomedullary responses to mental stress.

Authors:  Jason R Carter; David S Goldstein
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

2.  Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.

Authors:  Igor Elman; David Rott; Alan I Green; Daniel D Langleben; Scott E Lukas; David S Goldstein; Alan Breier
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

3.  Plasma catecholamines and blood volume in native Andeans during hypoxia and normoxia.

Authors:  Alfredo Gamboa; Jorge L Gamboa; Courtney Holmes; Yehonatan Sharabi; Fabiola Leon-Velarde; Gary J Fischman; Otto Appenzeller; David S Goldstein
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

4.  Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice.

Authors:  Saurabh Singh; Sanjay Pandey; Anant Narayan Bhatt; Richa Chaudhary; Vikas Bhuria; Namita Kalra; Ravi Soni; Bal Gangadhar Roy; Daman Saluja; Bilikere S Dwarakanath
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.